Isomorphic Labs is a London-based drug developer that’s owned and operated by Alphabet Inc. The company was founded in 2021 as an offshoot from DeepMind , Google’s multidisciplinary AI ...

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But can we trust drugs designed by a mind that isn't human?

Isomorphic Labs, a drug discovery company spun out of Google DeepMind, is about to make a historic breakthrough ... DeepMind’s revolutionary AlphaFold AI system gave birth to Isomorphic Labs, which ...

One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to address that disease,” Colin Murdoch, Isomorphic Labs president and Google ...

Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are also racing to use AI in drug discovery.

Precision oncology leader joins world-class team as company enters next phase of translating AI-driven drug discovery into life-changing medicines. As Chief Medical Officer, Dr. Wolf will bring ...

While AI-driven approaches tout increased speed and lower costs, commercial interests compromise scientific collaboration.